<unk>  is a recombinant human lysosomal beta glucuronidase that is FDA approved for the treatment of Mucopolysaccharidosis VII (MPS VII, Sly syndrome) in pediatric and adult patients. There is a Black Box Warning for this drug as shown here.  Common adverse reactions include infusion site extravasation, diarrhea, rash, anaphylaxis, infusion site swelling, peripheral swelling and pruritus.
Vestronidase alfa
Alglucosidase alfa
Tetracosactide
Ceruletide
Hydroxyethyl starch
Dornase alfa
Drotrecogin alfa
Pegloticase